A simple screening method for detecting bindings between oligopeptides andHLA-DR molecules on filter papers: Possible application for mapping of putative helper T-cell epitopes on MSP1 of Plasmodium falciparum
J. Fu et al., A simple screening method for detecting bindings between oligopeptides andHLA-DR molecules on filter papers: Possible application for mapping of putative helper T-cell epitopes on MSP1 of Plasmodium falciparum, MICROB IMMU, 44(4), 2000, pp. 249-257
Binding capacities of synthetic peptides to HLA-DR molecules were tested on
filter papers to identify putative helper T-cell epitopes on a malarial pr
otein. The antigen tested was the merozoite surface glycoprotein 1 (MSP1) o
f Plasmodium falciparum, a vaccine candidate targeting the asexual erythroc
ytic stage. Bindings between synthetic oligopeptides and HLA-DR molecules w
ere tested. Such bindings were not nonspecific, and a known helper T-cell e
pitope peptide showed positive binding to the restricting HLA-DR molecule.
By using this screening system, we observed the unequal distribution of HLA
-DR-binding peptides in 10 out of 17 MSP1 blocks tested. Block #6 of MSP1 s
eemed to show the highest frequency in the positive binding; on the other h
and, blocks #1 and #17, both of which were thought to be vaccine candidate
regions, contained fewer HLA-DR binding peptides, This was not inconsistent
with the results that block #17 was less stimulatory to peripheral T cells
than block #6, The peptides with positive binding to HLA-DR showed actual
epitope activities when we tested peptide-driven proliferation of human bul
k T-cell lines, and association between the two parameters was statisticall
y significant (P<0.001). For more detailed information for vaccine developm
ent, peptides with both IgG- and HLA-DR binding activities were mapped in b
lock #17 of MSP1. Together with these results, we demonstrate that our simp
le screening system seems to provide essential information for vaccine deve
lopment through uncovering locations of putative epitopes for human helper
T cells.